methoxyhydroxyphenylglycol has been researched along with Polycystic Ovarian Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Li, N; Shi, X; Zhang, L | 1 |
| Lobo, RA; Shoupe, D | 1 |
| Capelli, M; Flamigni, C; Grossi, G; Paradisi, R; Pasquali, R; Porcu, E; Rocchi, G; Venturoli, S | 1 |
| Eda, Y; Kitao, M; Nishigaki, A; Takahashi, K; Yoshino, K | 2 |
| Lobo, RA; Rosen, GF | 1 |
| Capelli, M; Fabbri, R; Flamigni, C; Grossi, G; Paradisi, R; Pasquali, R; Porcu, E; Venturoli, S | 1 |
| Artal, R; Barnes, RB; Lobo, RA | 1 |
8 other study(ies) available for methoxyhydroxyphenylglycol and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anxiety; Checklist; Depression; Diagnostic Self Evaluation; Dopamine; Female; Homovanillic Acid; Hostility; Humans; Hydroxyindoleacetic Acid; Infertility, Female; Methoxyhydroxyphenylglycol; Nervous System Diseases; Neurotransmitter Agents; Norepinephrine; Phobic Disorders; Polycystic Ovary Syndrome; Serotonin | 2011 |
Evidence for altered catecholamine metabolism in polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Carbidopa; Catecholamines; Drug Therapy, Combination; Female; Follicle Stimulating Hormone; Homovanillic Acid; Humans; Levodopa; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Pituitary Hormone-Releasing Hormones; Polycystic Ovary Syndrome | 1984 |
Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Brain; Bromocriptine; Catecholamines; Dopamine; Female; Gonadal Steroid Hormones; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Pituitary Hormones; Polycystic Ovary Syndrome; Pregnancy | 1993 |
Peripheral catecholamine metabolites and free testosterone in patients with polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Female; Humans; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Ovulation; Polycystic Ovary Syndrome; Testosterone; Ultrasonography | 1991 |
Plasma catecholamine metabolites and polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Catecholamines; Female; Follicle Stimulating Hormone; Glycols; Humans; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Phenylacetates; Polycystic Ovary Syndrome; Testosterone | 1990 |
Further evidence against dopamine deficiency as the cause of inappropriate gonadotropin secretion in patients with polycystic ovary syndrome.
Topics: Adult; Disulfiram; Dopamine; Female; Gonadotropins; Growth Hormone-Releasing Hormone; Homovanillic Acid; Humans; Luteinizing Hormone; Methoxyhydroxyphenylglycol; Polycystic Ovary Syndrome; Reference Values | 1987 |
Evidence for a hypothalamic alteration of catecholamine metabolism in polycystic ovary syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Carbidopa; Catecholamines; Dopamine; Female; Homovanillic Acid; Humans; Hypothalamus; Methoxyhydroxyphenylglycol; Polycystic Ovary Syndrome | 1988 |
Peripheral dopamine metabolism in polycystic ovary syndrome.
Topics: Adult; Carbidopa; Dopamine; Female; Homovanillic Acid; Humans; Levodopa; Methoxyhydroxyphenylglycol; Norepinephrine; Polycystic Ovary Syndrome | 1987 |